|
Diabetes Care, Vol 8, Issue 3 290-299, Copyright © 1985 by American Diabetes Association
Glucose-induced alterations in nerve metabolism: current perspective on the pathogenesis of diabetic neuropathy and future directions for research and therapy
DA Greene, S Lattimer, J Ulbrecht and P Carroll
Recent animal and in vitro studies have identified several interrelated
metabolic abnormalities in diabetic nerve that are attributable to elevated
ambient glucose concentrations. In combination, these metabolic changes may
induce a variety of biochemical and biophysical alterations in peripheral
nerve that are highly relevant to the pathogenesis of diabetic neuropathy.
This article reviews the current status of several of these metabolic
defects and describes ways in which their interaction could lead to
pathogenetically important changes in nerve metabolism, function, and
structure. Areas of related future research are also discussed.

CiteULike Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
S. Cellek, N. A. Foxwell, and S. Moncada
Two Phases of Nitrergic Neuropathy in Streptozotocin-Induced Diabetic Rats
Diabetes,
September 1, 2003;
52(9):
2353 - 2362.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Verrotti, T. Giuva, G. Morgese, and F. Chiarelli
Topical Review : New Trends in the Etiopathogenesis of Diabetic Peripheral Neuropathy
J Child Neurol,
June 1, 2001;
16(6):
389 - 394.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
I. G. OBROSOVA, C. VAN HUYSEN, L. FATHALLAH, X. CAO, M. J. STEVENS, and D. A. GREENE
Evaluation of {alpha}1-adrenoceptor antagonist on diabetes-induced changes in peripheral nerve function, metabolism, and antioxidative defense
FASEB J,
August 1, 2000;
14(11):
1548 - 1558.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
R. E. Schmidt, D. A. Dorsey, L. N. Beaudet, S. B. Plurad, C. A. Parvin, and M. S. Miller
Insulin-like Growth Factor I Reverses Experimental Diabetic Autonomic Neuropathy
Am. J. Pathol.,
November 1, 1999;
155(5):
1651 - 1660.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Gerbi, J.-M. Maixent, J.-L. Ansaldi, M. Pierlovisi, T. Coste, J.-F. Pelissier, P. Vague, and D. Raccah
Fish Oil Supplementation Prevents Diabetes-Induced Nerve Conduction Velocity and Neuroanatomical Changes in Rats
J. Nutr.,
January 1, 1999;
129(1):
207 - 213.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. C. B. Ko, B. Ruepp, K. M. Bohren, K. H. Gabbay, and S. S. M. Chung
Identification and Characterization of Multiple Osmotic Response Sequences in the Human Aldose Reductase Gene
J. Biol. Chem.,
June 27, 1997;
272(26):
16431 - 16437.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. B. Kalmansohn, R. W. Kalmansohn, C. H. Markham, and D. L. Schiff
Treatment of Diabetic Neuropathy with Pentoxifylline: Case Report
Angiology,
April 1, 1988;
39(4):
371 - 374.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Leese
Diabetic Cranial Mononeuropathies: A Patient's Perspective
The Diabetes Educator,
January 1, 1988;
14(6):
527 - 531.
[PDF]
|
 |
|
Copyright © 1985 by the American Diabetes Association.
|
|
| |
|